• 1
    Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-350.
  • 2
    Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-2047.
    Direct Link:
  • 3
    Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000-3004.
  • 4
    Ascha MS, Hanouneh IA, Lopez R, Tamini TA-R, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. HEPATOLOGY 2010; 51: 1972-1978.
  • 5
    Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
  • 6
    Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: molehill or mountain? HEPATOLOGY 2008; 47: 1431-1433.
  • 7
    Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121.
  • 8
    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
  • 9
    Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350.
  • 10
    Adams LA, Talwalkar JA. Diagnostic evaluation of nonalcoholic fatty liver disease. J Clin Gastroenterol 2006; 40( Suppl 1): S34-S38.
  • 11
    Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008; 28: 386-395.
  • 12
    Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6: 9.
  • 13
    Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziuo PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138: W1-W12.
  • 14
    Harbord RM, Whiting P, Sterne JA, Egger M, Deeks JJ, Shang A, Bachmann LM. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol 2008; 61: 1095-1103.
  • 15
    Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006; 187: 271-281.
  • 16
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
  • 17
    Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882-893.
  • 18
    Gosink BB, Lemon SK, Scheible W, Leopold GR. Accuracy of ultrasonography in diagnosis of hepatocellular disease. AJR Am J Roentgenol 1979; 133: 19-23.
  • 19
    Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440-442.
  • 20
    Youssef MM. Ultrasonography liver disease diagnosis. Ann Clin Res 1980; 12( Suppl 26): 1-47.
  • 21
    Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 1981; 22: 130-135.
  • 22
    Spuhler A, Pösl H, Sander R, Götz U. Ultrasonography in the diagnosis of fatty liver (author's transl) [in German]. Leber Magen Darm 1981; 11: 15-20.
  • 23
    Pirovino M, Grauer W, Götz A, Huber M, Altorfer J, Maranta E, et al. Importance of ultrasonography in the diagnosis of diffuse parenchymal disorders of the liver [in German]. Schweiz Med Wochenschr 1982; 112: 525-526.
  • 24
    Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol 1983; 18: 743-747.
  • 25
    Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
  • 26
    Sanford NL, Walsh P, Matis C, Baddeley H, Powell LW. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 1985; 89: 186-191.
  • 27
    Berrut C, Curati W, de Gautard R, Widmann JJ, Godin N, Loizeau E. The role of ultrasonography in the diagnosis of diffuse liver disease [in German]. Schweiz Med Wochenschr 1986; 116: 215-218.
  • 28
    Cusumano S, De Mori E, Buschini M. Clinical statistics on the agreement of echographic and bioptic findings in diffuse liver diseases. Minerva Med 1986; 77: 889-892.
  • 29
    Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 1986; 146: 1011-1015.
  • 30
    Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986; 292: 13-15.
  • 31
    Tam KM, Wu JS. Ultrasonographic diagnosis of fatty liver [in Chinese]. Taiwan Yi Xue Hui Za Zhi 1986; 85: 45-53.
  • 32
    Coulson IH, McKenzie J, Neild VS, Joseph AE, Marsden RA. A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy. Br J Dermatol 1987; 116: 491-495.
  • 33
    Forsberg L, Floren CH, Hederstrom E, Prytz H. Ultrasound examination in diffuse liver disease. Clinical significance of enlarged lymph nodes in the hepato-duodenal ligament. Acta Radiol 1987; 28: 281-284.
  • 34
    Sato Y, Ohta Y, Fujiwara K, Oka H. Loss of echoes from the gallbladder wall in diagnosis of fatty infiltration of the liver. Scand J Gastroenterol 1987; 22: 1160-1164.
  • 35
    Savarino V, Magnolia MR, Scalabrini P. Are sonographic and radionuclide investigations alternative or complementary in diagnosing liver disease? A comparison between these methods and laparobiopsy. Ital J Gastroenterol 1987; 19: 5-9.
  • 36
    Celle G, Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Dodero M. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci 1988; 33: 467-471.
  • 37
    Lössner C, Cuno S, Kleine S, Kleine FD. Value of ultrasound tomography in the diagnosis and follow-up of fatty liver [in German]. Dtsch Z Verdau Stoffwechselkr 1988; 48: 22-26.
  • 38
    Saitoh S, Nagamine T, Takagi H, Sekiguchi T, Uehara M, Yuasa K, et al. Diagnosis of fatty liver—comparison of ultrasonographic and computed tomographic findings to histological features [in Japanese]. Nippon Shokakibyo Gakkai Zasshi 1988; 85: 2658-2665.
  • 39
    Yang PM, Huang GT, Lin JT, Sheu JC, Lai MY, Su IJ, et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver diseases: a prospective study. Taiwan Yi Xue Hui Za Zhi 1988; 87: 966-977.
  • 40
    Ferrari F, Fagioli Zucchi A, Saloni E , Marini M, Frosini G. Variability of sonographic changes in diffuse hepatic diseases. Ital J Gastroenterol 1989; 21: 155-158.
  • 41
    Nishimura N. Non-invasive quantitative assessment of hepatic fatty change by the hepatic ultrasound velocity and attenuation coefficient. Jpn J Med Ultrason 1989; 16: 31-40.
  • 42
    Joseph AEA, Saverymuttu SH. Ultrasound in the assessment of diffuse parenchymal liver disease. Clin Radiol 1991; 44: 219-221.
  • 43
    Bloom SL, Ireland A, Ryley NG, Chapman RW, Lindsell D. Correlation between hepatic ultrasound and histology. Eur J Gastroenterol Hepatol 1992; 4: 39-42.
  • 44
    Castellano G, González A, Colina F, Rodríguez S, Muñoz MT, Sánchez F, et al. Diagnostic value of the hepatic echo-histogram in chronic hepatopathy [in Spanish]. Rev Esp Enferm Dig 1993; 84: 373-380.
  • 45
    Nagata O, Uto K, Sugihara H, Nohara Y, Mishima Y, Yoshida M, et al. Evaluation study of measurement method in ultrasonic diagnosis of fatty change of the liver. Based on trace histogram examination. Jpn J Med Ultrason 1993; 20: 9-16.
  • 46
    Cardi M, Muttillo IA, Amadori L, Petroni R, Mingazzini P, Barillari P, et al. Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases. Dig Dis Sci 1997; 42: 546-548.
  • 47
    Dietrich CF, Wehrmann T, Zeuzem S, Braden B, Caspary WF, Lembcke B. Analysis of hepatic echo patterns in chronic hepatitis C [in German]. Ultraschall Med 1999; 20: 9-14.
  • 48
    Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-324.
  • 49
    Mathiesen UL, Franzén LE, Aselius H, Resjö M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-522.
  • 50
    Lakomy EA, Stalke P, Sikorska K, Pawlak A, Michalski Z, Witczak-Malinowska K, et al. Liver steatosis in chronic hepatitis C patients. Ann Acad Med Gedanensis 2004; 34: 183-189.
  • 51
    Hepburn MJ, Vos JA, Fillman EP, Lawitz EJ. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol 2005; 5: 14.
  • 52
    Kim SH, Lee JM, Kim JH, Kim KG, Han JK, Lee KH, et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images—initial experience. Radiology 2005; 234: 793-803.
  • 53
    Palmentieri B, De Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38: 485-489.
  • 54
    Riley TR III, Mendoza A, Bruno MA. Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image. Dig Dis Sci 2006; 51: 982-985.
  • 55
    Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-2715.
    Direct Link:
  • 56
    Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244.
  • 57
    Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, et al. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007; 41: 624-629.
  • 58
    Salueña I, Ortega L, Devesa MJ, López-Alonso G, Taxonera C, Díaz-Rubio M, Ladero JM. Utility of liver biopsy in the etiologic diagnosis of biochemical liver abnormalities of unknown cause [in Spanish]. Gastroenterol Hepatol 2007; 30: 325-330.
  • 59
    Chen CH, Lin ST, Yang CC, Yeh YH, Kuo CL, Nien CK. The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C. Dig Dis Sci 2008; 53: 1699-1706.
  • 60
    de Moura AA, Cotrim HP, Barbosa DB, de Athayde LG, Santos AS, Bitencourt AG, et al. Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound. World J Gastroenterol 2008; 14: 1415-1418.
  • 61
    Ahmed L, Salama H, Ahmed R, Hamdy S, Al-Akel W, Shafi SA, et al. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis. Arab J of Gastroenterol 2009; 10: 14-20.
  • 62
    Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-1067.
  • 63
    Guajardo-Salinas GE, Hilmy A. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Obes Surg 2010; 20: 1647-1653.
  • 64
    Soresi M, Giannitrapani L, Florena AM, La Spada E, Di Gesaro V, Rappa F, et al. Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. Clin Radiol 2009; 64: 1181-1187.
  • 65
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, et al. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation 2009; 88: 575-581.
  • 66
    Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52: 579-585.
  • 67
    Scatarige JC, Scott WW, Donovan PJ, Siegleman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984; 3: 9-14.
  • 68
    Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96: 542-547.
  • 69
    Pozzato C, Radaelli G, Dall'Asta C, Verduci E, Villa A, Villa C, et al. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings. J Pediatr Gastroenterol Nutr 2008; 47: 493-499.
  • 70
    Edens MA, van Ooijen PM, Post WJ, Haagmans MJF, Kristanto W, Sijens PE, et al. Ultrasonography to quantify hepatic fat content: validation by (1)h magnetic resonance spectroscopy. Obesity (Silver Spring) 2009; 17: 2239-2244.
  • 71
    Mancini M, Prinster A, Annuzzi G, Liuzzi R, Giacco R, Medaqli C, et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism 2009; 58: 1724-1730.
  • 72
    Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al. The effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 2010; 33: 2156-2163.
  • 73
    Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685.
  • 74
    Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, et al. Clinical, laboratory, and histological associations in adults with nonalcoholic fatty liver disease. HEPATOLOGY 2010; 52: 913-924.
  • 75
    Juluri R, Vuppalanchi R, Olson J, Unalp A, Van Natta ML, Cummings OW, et al. Generalizability of the nonalcoholic steatohepatitis clinical research network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 2011; 45: 55-58.